Sebia cuts margin on the first lien of €709m acquisition loan
Sebia, the French medical diagnostics firm, has tightened pricing on the first lien of its €709m-equivalent acquisition loan in response to strong demand from lenders.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: